Acumen Pharmaceuticals
ABOS
ABOS
52 hedge funds and large institutions have $173M invested in Acumen Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
52% less capital invested
Capital invested by funds: $357M → $173M (-$184M)
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$2.65M | |
| 3 | +$951K | |
| 4 |
HF
HRT Financial
New York
|
+$900K |
| 5 |
E
Ergoteles
New York
|
+$848K |
Top Sellers
| 1 | -$8.46M | |
| 2 | -$3.68M | |
| 3 | -$2.56M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.03M |
| 5 |
MCM
Moore Capital Management
New York
|
-$122K |